JP2023507508A5 - - Google Patents

Info

Publication number
JP2023507508A5
JP2023507508A5 JP2022538109A JP2022538109A JP2023507508A5 JP 2023507508 A5 JP2023507508 A5 JP 2023507508A5 JP 2022538109 A JP2022538109 A JP 2022538109A JP 2022538109 A JP2022538109 A JP 2022538109A JP 2023507508 A5 JP2023507508 A5 JP 2023507508A5
Authority
JP
Japan
Prior art keywords
hydrochloride
methyl
benzylpiperidine
phenylpyridazine
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022538109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023507508A (ja
JP7725475B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/086996 external-priority patent/WO2021123145A1/en
Publication of JP2023507508A publication Critical patent/JP2023507508A/ja
Publication of JP2023507508A5 publication Critical patent/JP2023507508A5/ja
Application granted granted Critical
Publication of JP7725475B2 publication Critical patent/JP7725475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022538109A 2019-12-19 2020-12-18 シグマ-1受容体リガンド及びその使用 Active JP7725475B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19306705.5 2019-12-19
EP19306705 2019-12-19
PCT/EP2020/086996 WO2021123145A1 (en) 2019-12-19 2020-12-18 Sigma-1 receptor ligands and uses thereof

Publications (3)

Publication Number Publication Date
JP2023507508A JP2023507508A (ja) 2023-02-22
JP2023507508A5 true JP2023507508A5 (https=) 2023-12-26
JP7725475B2 JP7725475B2 (ja) 2025-08-19

Family

ID=69232740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538109A Active JP7725475B2 (ja) 2019-12-19 2020-12-18 シグマ-1受容体リガンド及びその使用

Country Status (6)

Country Link
US (1) US20230049619A1 (https=)
EP (1) EP4077310B1 (https=)
JP (1) JP7725475B2 (https=)
CN (1) CN114981260A (https=)
CA (1) CA3157428A1 (https=)
WO (1) WO2021123145A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12612371B2 (en) 2019-12-19 2026-04-28 Universite De Strasbourg Sigma-1 receptor ligands and therapeutic uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB858792A (en) * 1958-02-10 1961-01-18 Sandoz Ltd New pyridazine derivatives and processes for their manufacture
GB0204252D0 (en) 2002-02-23 2002-04-10 Oxford Glycosciences Uk Ltd Novel compounds
US8404852B2 (en) * 2003-01-31 2013-03-26 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
AR042956A1 (es) * 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
ATE522249T1 (de) 2007-07-26 2011-09-15 Novartis Ag Organische verbindungen
WO2010131145A1 (en) 2009-05-12 2010-11-18 Pfizer Limited Cyclobutenedione derivatives
CA2761279A1 (en) 2009-05-20 2010-11-25 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
CN102241667B (zh) * 2010-05-14 2013-10-23 中国人民解放军军事医学科学院毒物药物研究所 1-[(4-羟基哌啶-4基)甲基]吡啶-2(1h)-酮衍生物及其制备方法和用途
BR112014015197A8 (pt) 2011-12-21 2017-06-13 Novira Therapeutics Inc agentes antivirais de hepatite b
AR098215A1 (es) * 2013-10-29 2016-05-18 Takeda Pharmaceuticals Co Compuesto heterocíclico
WO2017222952A1 (en) * 2016-06-23 2017-12-28 Merck Sharp & Dohme Corp. 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
WO2019068771A1 (en) * 2017-10-04 2019-04-11 Esteve Pharmaceuticals, S.A. USE OF SIGMA RECEPTOR LIGANDS AGAINST AGE-RELATED COGNITIVE DISORDERS

Similar Documents

Publication Publication Date Title
JP2018511587A5 (https=)
JP2007519754A5 (https=)
DE69622992T2 (de) Substituierte heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
JPWO2005037269A1 (ja) 新規ピペリジン誘導体
NZ573832A (en) N-(4-{ 2-[4-aryl-piperazin-1-yl]ethyl} cyclohexyl)-acetamide derivatives for the treatment of neuropsychiatric disorders
JP2006022108A5 (https=)
HRP20230290T1 (hr) Derivati triazina za liječenje bolesti u vezi sa neurotrofinima
RU2009122197A (ru) Производные 1,2,4-триазолы в качестве ингибиторов сигма-рецептора
JP2005510500A5 (https=)
JP2014532640A5 (https=)
EA016948B1 (ru) Модуляторы никотиновых ацетилхолиновых рецепторов
JP2021514963A5 (https=)
JP2009519929A (ja) オキサゾリジノン化合物及び代謝型グルタミン酸レセプター増強剤としてのそれらの使用
KR101894681B1 (ko) Taar 리간드로서의 치환된 아제티딘 유도체
JP2008520637A5 (https=)
JP2019537592A5 (https=)
JP2023507508A5 (https=)
JP2009528317A5 (https=)
BE1009571A3 (fr) Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant.
JP2024540318A5 (https=)
JP2000086603A (ja) 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体
RU2690154C2 (ru) Производные морфолин-пиридина
JP2009528319A5 (https=)
JP2010540629A (ja) カルシウムチャネル遮断薬としての置換アリールスルホン誘導体
WO2004046107A1 (en) Indole derivatives as somatostatin agonists or antagonists